Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
T-Mobile US
TMUS
|
+$1.03B |
| 2 |
iShares Bitcoin Trust
IBIT
|
+$978M |
| 3 |
UnitedHealth
UNH
|
+$636M |
| 4 |
Nasdaq
NDAQ
|
+$575M |
| 5 |
Columbia Research Enhanced Core ETF
RECS
|
+$563M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.57B |
| 2 |
NVIDIA
NVDA
|
+$1B |
| 3 |
iShares Silver Trust
SLV
|
+$754M |
| 4 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$662M |
| 5 |
Microsoft
MSFT
|
+$632M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.3% |
| 2 | Financials | 1.21% |
| 3 | Consumer Discretionary | 1.07% |
| 4 | Industrials | 1.02% |
| 5 | Communication Services | 0.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCPH
9076
CALL
DELISTED
scPharmaceuticals
SCPH
| $49.1K | ﹤0.01% |
+12,900
| New | +$40K |
|
9077
Solidion Technology
STI
$66.4M
| $49K | ﹤0.01% |
+12,445
| New | +$53.5K |
|
9078
Genius Group
GNS
$31.1M
| $48.6K | ﹤0.01% |
+35,702
| New | +$14.2K |
|
|
PHK
9079
PIMCO High Income Fund
PHK
$861M
| $48.4K | ﹤0.01% |
+10,090
| New | +$47.7K |
|
9080
Mammoth Energy Services
TUSK
$160M
| $48.4K | ﹤0.01% |
17,268
+5,621
| +48% | +$14.4K |
|
9081
PUT
NovaGold Resources
NG
$3.47B
| $48.3K | ﹤0.01% |
+11,800
| New | +$44.2K |
|
|
CMPS
9082
CALL
Compass Pathways
CMPS
$1.87B
| $48.2K | ﹤0.01% |
17,200
+6,400
| +59% | +$24.1K |
|
|
SGMO
9083
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $47.9K | ﹤0.01% |
88,500
+34,700
| +64% | +$20.6K |
|
|
ITRG
9084
Integra Resources
ITRG
$564M
| $47.6K | ﹤0.01% |
+31,716
| New | +$50.9K |
|
9085
PUT
Rayonier Advanced Materials
RYAM
$563M
| $47.4K | ﹤0.01% |
12,300
-266,900
| -96% | -$1.12M |
|
9086
CALL
Compass Therapeutics
CMPX
$409M
| $47.3K | ﹤0.01% |
18,200
-24,400
| -57% | -$50.3K |
|
9087
Clene
CLNN
$52.9M
| $47.3K | ﹤0.01% |
+12,095
| New | +$39.4K |
|
|
KEEL
9088
CALL
Keel Infrastructure Corp
KEEL
$2.26B
| $47.1K | ﹤0.01% |
56,760
+32,048
| +130% | +$29.6K |
|
9089
Ovid Therapeutics
OVID
$553M
| $47K | ﹤0.01% |
+142,597
| New | +$43K |
|
|
TGB
9090
PUT
Trekor Metals
TGB
$3.16B
| $46.9K | ﹤0.01% |
14,900
-11,000
| -42% | -$25.7K |
|
9091
Sigma Lithium
SGML
$1.27B
| $46.9K | ﹤0.01% |
+10,425
| New | +$68.8K |
|
9092
PUT
Quantum-Si Incorporated
QSI
$171M
| $46.6K | ﹤0.01% |
23,800
-13,600
| -36% | -$20.1K |
|
|
CODX
9093
Co-Diagnostics
CODX
$10.7M
| $46.6K | ﹤0.01% |
5,542
+4,204
| +314% | +$39.3K |
|
9094
PUT
LiveWire
LVWR
$240M
| $46.5K | ﹤0.01% |
+10,100
| New | +$30.3K |
|
|
CGC
9095
PUT
Canopy Growth
CGC
$422M
| $46.4K | ﹤0.01% |
+37,600
| New | +$50K |
|
|
9096
PUT
Sigma Lithium
SGML
$1.27B
| $46.4K | ﹤0.01% |
10,300
-600
| -6% | -$3.96K |
|
9097
Coherus Oncology
CHRS
$181M
| $46.3K | ﹤0.01% |
+63,313
| New | +$54.7K |
|
9098
PUT
PetMed Express
PETS
$38.6M
| $46.1K | ﹤0.01% |
+13,900
| New | +$49.5K |
|
9099
CALL
Siebert Financial
SIEB
$78.5M
| $45.5K | ﹤0.01% |
+10,300
| New | +$41.8K |
|
9100
Research Solutions
RSSS
$76.6M
| $45.4K | ﹤0.01% |
15,816
-15,421
| -49% | -$42.2K |
|
Similar funds
Jane Street's Q2 2025 Portfolio in Review
As of Q2 2025, Jane Street held 11,384 positions worth $506B, up 27% from $397B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Jane Street deployed $36.7B of net new capital in Q2 2025, opening 2,110 new positions and adding to 3,865 existing holdings. Its largest new stake was Nasdaq: 7,205,132 shares worth $644M.
By sector, the portfolio is most concentrated in Technology at 2.3% of assets, down from 3.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $1.57B trimmed.
- Jane Street's largest Q2 2025 buy was Nasdaq: 7,205,132 shares worth $644M.
- Jane Street added most to T-Mobile US in Q2 2025, an estimated $1.03B increase.
- Jane Street's biggest Q2 2025 reduction was Broadcom, cutting an estimated $1.57B.
- Jane Street fully exited iShares Core MSCI Total International Stock ETF in Q2 2025, selling an estimated $662M.
- Jane Street's ten largest holdings make up 39% of its $506B portfolio in Q2 2025.
- Jane Street opened 2,110 new positions and closed 1,895 in Q2 2025.
- Jane Street's portfolio value rose 27% quarter-over-quarter to $506B.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.